News

Public Health Scotland (PHS) has today published its second Annual Vaccination and Immunisation report. It reviews the activities of Scotland’s vaccination and immunisation programme in 2024 and offers insight from the successes and challenges of the country’s largest coordinated public health programme.

Public Health Scotland (PHS) welcomes the latest steps to create a smokefree generation with the ban on the sale and supply of single-use vapes in Scotland, which comes into effect on 1 June 2025.

As measles cases continue to increase across Europe and other parts of the world, Public Health Scotland (PHS) is encouraging the public to take up the offer of the Measles, Mumps and Rubella (MMR) vaccine.

Following a detailed review by the Joint Committee on Vaccination and Immunisation (JCVI), the UK’s independent expert group on vaccines, Public Health Scotland (PHS) is working with the Scottish Government and colleagues across NHS Boards to make some changes to Scotland’s childhood vaccination programme.

Following four years of invaluable leadership and guidance, the Chair of Public Health Scotland’s Board, Angiolina Foster, will come to the end of her term on 31 August 2025.

Public Health Scotland (PHS) is encouraging everyone offered a COVID-19 vaccine this spring to come forward, get vaccinated and stay protected - because COVID-19 hasn’t disappeared.

Public Health Scotland (PHS) has published its second Corporate Parenting and Vision Plan set to cover 2025 to 2028.

Public Health Scotland (PHS) is urging caution, following reports of an increase in fatal and near fatal overdoses in people using heroin in recent weeks.

The Collaboration for Health Equity in Scotland launches plans to bring about significant change to reduce health inequalities in three of Scotland’s local authority areas - Aberdeen City, North Ayrshire and South Lanarkshire.

A new study from Public Health Scotland, in collaboration with the University of Strathclyde, shows a 62% reduction in respiratory syncytial virus (RSV) related hospitalisations among the eligible age group following introduction of the vaccine.